Drug Shortage Report for KADIAN

Last updated on 2020-01-13 History
Report ID 101619
Drug Identification Number 02184451
Brand name KADIAN
Common or Proper name MORPHINE SULFATE
Company Name BGP PHARMA ULC
Market Status MARKETED
Active Ingredient(s) MORPHINE SULFATE
Strength(s) 100MG
Dosage form(s) CAPSULE (SUSTAINED-RELEASE)
Route of administration ORAL
Packaging size 50BT
ATC code N02AA
ATC description OPIOIDS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-11-27
Estimated end date 2020-01-06
Actual end date 2020-01-10
Shortage status Resolved
Updated date 2020-01-13
Company comments
Health Canada comments
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2019-12-19 English Compare
v2 2019-12-19 French Compare
v3 2020-01-13 English Compare
v4 2020-01-13 French Compare